Testing a colon bypass device during colorectal cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial studies a device (CG-100) placed inside the bowel to see if it can improve safety and outcomes during surgery for colorectal cancer. You would be asked to follow extra study check-ins after your operation, and the team would monitor whether the device works as intended.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with colorectal cancer
- You are planning an elective mesorectal excision surgery (open, laparoscopic, or robotic) that will create an an anastomosis within 10 cm of the anus
- You are willing to do all scheduled follow-up visits and procedures required by the study
- You are preparing for surgery with mechanical bowel preparation, and you will provide written informed consent
- Your medical situation fits the study limits (no major recent surgeries/procedures, no serious infections, and no severe lab/health issues)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a device called COLO-BT can be a safer, effective alternative to an ileostomy (a temporary or longer-term opening from the intestine to the skin). It’s for certain adults having a bowel connection low in the pelvis, where leak risk matters.
This trial tests whether a temporary stoma (a bag on the belly) can be safely avoided in some people having rectal cancer surgery. The goal is to see if it's okay to skip the stoma in those with a low risk of complications.
This trial looks at different ways to help bowel and anal function (how well you control gas and stool) in people with rectal cancer who are planning a sphincter-preserving surgery. It may help find an approach that improves quality of life after treatment.
This study looks at patterns in the gut microbiome (gut bacteria) and gut chemicals (metabolites) to predict how rectal cancer may do after planned surgery. By understanding these markers, researchers hope to better forecast prognosis and tailor follow-up.
This trial tests a device called Colovac that protects the connection made during colon surgery for cancer. It may help patients who need a temporary colostomy bag heal better.
This Phase 3 study tests SGM-101, a drug used during surgery to help doctors better outline primary, recurrent, and spread (metastatic) colorectal cancer. It may improve how completely tumors are identified and removed during an operation.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.